CMMB Chemomab Therapeutics
- 1.895
- -0.395-17.25%
- 1.950
- +0.055+2.90%
Chemomab Therapeutics News
Chemomab Therapeutics | F-3: Registration statement for specified transactions by certain foreign private issuers
Chemomab Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Chemomab Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Chemomab Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Chemomab Therapeutics | F-3/A: Registration statement for specified transactions by certain foreign private issuers (Amendment)
Chemomab Therapeutics | F-3: Registration statement for specified transactions by certain foreign private issuers
Chemomab Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Chemomab Therapeutics | 8-K: Current report
Chemomab Therapeutics | 8-K: Current report
Chemomab Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Chemomab Therapeutics | 8-K: Chemomab Therapeutics Announces First Quarter 2023 Financial Results and Provides a Corporate Update
Chemomab Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Chemomab Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Chemomab Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Chemomab Therapeutics | 8-K: Current report
Chemomab Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Chemomab Therapeutics | 8-K: Current report
Chemomab Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
Chemomab Therapeutics | 8-K: Current report
Chemomab Therapeutics | 8-K: Current report
Analysis
Price Target
No Data
